# HBAN Medtech Syndicate

> HBAN Medtech Syndicate is a VC fund backing Medical Device, Medical and Health Care. See 13 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 13
- Last investment: Jun 2026
- Lead investor: 15%
- Last updated: Aug 2026

HBAN Medtech Syndicate is a VC fund focused on Medical Device and Medical. HBAN Medtech Syndicate

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.3M–$11M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 6 | 46% |
| Medical | 5 | 38% |
| Health Care | 4 | 31% |
| Hospital | 1 | 8% |
| Biotechnology | 1 | 8% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 38% |
| Funding Round | 4 | 31% |
| Series B | 1 | 8% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Neurobell | NeuroBell are developing a novel medical device providing portable EEG monitoring with real-time &automated neonatal seizure alerts at the bedside. | $5.5M |  | Jun 29, 2026 |  |
| Neurobell | NeuroBell are developing a novel medical device providing portable EEG monitoring with real-time &automated neonatal seizure alerts at the bedside. | $2.1M | Seed | Jan 08, 2024 |  |
| SymPhysis Medical | SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer. | $1.7M | Seed | Dec 21, 2023 |  |
| FeelTect | FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous. | $1.6M |  | Dec 20, 2023 |  |
| FeelTect | FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous. | $1.6M | Seed | Dec 20, 2023 |  |
| X-BOLT Orthapaedics | X-BOLT Orthopaedics developed a novel expanding bolt device, with associated implants and instrumentation systems, for internal bone fixation in osteoporotic hip fractures. X-BOLT hip plating and nailing systems allow surgeons choice to treat all morphologies of proximal femoral fractures. | $3.5M | Venture - Series Unknown | Oct 29, 2023 |  |
| Bluedrop Medical | It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.5M |  | Mar 31, 2023 |  |
| Bluedrop Medical | It has been estimated that up to 25% of diabetics will develop a foot ulcer at some point in their life. One of the main causes is peripheral neuropathy, which results in a patient losing sensation in their feet. Of the millions who develop ulcers every year, hundreds of thousands will require amputation due to infection. In 2014, Ireland recordedan increase in the number of amputations as a result of diabetes, with 8 limbs being lost every week. | $11.4M | Seed | Mar 31, 2023 |  |
| Signum Surgical | Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process. | $2.9M | Venture - Series Unknown | Sep 20, 2022 |  |
| Deciphex | Founded in 2017, Deciphex aims to transform diagnostic workflows through AI-powered digital pathology to improve patient outcomes worldwide. Its two flagship platforms target distinct markets: Diagnexia connects global subspecialty pathologists for rapid diagnostics and backlog reduction, while Patholytix accelerates drug development throughoptimized preclinical safety assessments. By automating routine tasks, these platforms enable pathologists to focus on complex cases while delivering faster, more reliable diagnoses. Through this combination of AI innovation and clinical expertise, Deciphex is advancing both healthcare delivery and therapeutic development. | $11.5M | Series B | May 19, 2022 |  |

10 of 13 investments shown.

## Co-investors
- [Irrus Investments](https://shizune.co/investors/profile/irrus-investments) — VC Fund, 8 deals together
- [Western Development Commission](https://shizune.co/investors/profile/western-development-commission) — VC Fund, 7 deals together
- [Furthr VC](https://shizune.co/investors/profile/dbic-ventures) — VC Fund, 6 deals together
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund, 5 deals together
- [Atlantic Bridge](https://shizune.co/investors/profile/atlantic-bridge) — VC Fund, 4 deals together
- [Ascentifi](https://shizune.co/investors/profile/ascentifi) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund
- [NDRC](https://shizune.co/investors/profile/ndrc) — VC Fund
- [Act Venture Capital](https://shizune.co/investors/profile/act-venture-capital) — VC Fund

## Featured in investor lists
- [Health Care Investors in Ireland](https://shizune.co/investors/health-care-investors-ireland)
- [Health Care VC Funds in Ireland](https://shizune.co/investors/health-care-vc-funds-ireland)
- [All Investors in Ireland](https://shizune.co/investors/investors-ireland)
- [All VC Funds in Ireland](https://shizune.co/investors/vc-funds-ireland)
- [Medical Device Investors in Ireland](https://shizune.co/investors/medical-device-investors-ireland)
- [Medical Device VC Funds in Ireland](https://shizune.co/investors/medical-device-vc-funds-ireland)

## FAQ

### What does HBAN Medtech Syndicate invest in?

HBAN Medtech Syndicate invests primarily in Medical Device, Medical and Health Care startups, most often at Seed and Funding Round stage. Most of the 13 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is HBAN Medtech Syndicate's check size?

HBAN Medtech Syndicate typically joins rounds of $1.3M–$11M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds HBAN Medtech Syndicate participates in.

### When did HBAN Medtech Syndicate last invest?

The most recent investment recorded for HBAN Medtech Syndicate closed in Jun 2026. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co